OMEGA DIAGNOSTICS GR

ODX
Delayed Quote. Delayed  - 01/25 11:35:21 am
78GBX +11.43%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: March 2020 2021
Net sales1 9,8212,6
EBITDA1 0,891,60
Operating profit (EBIT)1 -0,310,90
Operating Margin -3,19%7,14%
Pre-Tax Profit (EBT)1 -8,300,50
Net income1 -6,830,50
Net margin -69,5%3,97%
EPS2 -0,050,00
Dividend per Share --
Last update 07/14/2020-
1 GBP in Million
2 GBP
Estimates
Finances - Leverage
Fiscal Period: March 2020 2021
Net Debt1 0,87-
Net Cash position1 -7,10
Leverage (Debt / EBITDA) 0,97x-4,44x
Free Cash Flow1 -1,61-2,20
ROE (Net Profit / Equities) -2,91%3,00%
Shareholders' equity1 23516,7
ROA (Net Profit / Asset) --
Assets1 --
Book Value Per Share2 0,100,14
Cash Flow per Share --
Capex1 2,153,70
Capex / Sales 21,9%29,4%
Last update 07/14/202011/30/2020
1 GBP in Million
2 GBP
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2021e 2022e
Capitalization 140 M GBP -
Entreprise Value (EV) 133 M GBP 140 M GBP
Valuation 2021e 2022e
P/E ratio (Price / EPS) 260x -
Capitalization / Revenue 11,1x -
EV / Revenue 10,6x -
EV / EBITDA 83,3x -
Yield (DPS / Price) - -
Price to book (Price / BVPS) 5,61x -
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) 7,14% -
Operating Leverage (Delta EBIT / Delta Sales) 13,7x -1,00x
Net Margin (Net Profit / Revenue) 3,97% -
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 3,00% -
Rate of Dividend - -
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   29,4% -
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
EPS & Dividend